Patent assignee · BE · COMPANY

ThromboGenics NV

21Patents
20Active
21Granted
50Portfolio score

Filing activity: Dec 5, 2003 → Jun 27, 2014 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7547435B2 Pharmacological vitreolysis Chemistry; Metallurgy 11 Expired
US8697444B2 Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells Chemistry; Metallurgy 11 Active
US7803368B2 Pharmacological vitreolysis Chemistry; Metallurgy 9 Active
US7914783B2 Pharmacological vitreolysis Chemistry; Metallurgy 9 Active
US7867489B2 Pharmacological vitreolysis Chemistry; Metallurgy 9 Active
US8383105B2 Pharmacological vitreolysis Chemistry; Metallurgy 8 Active
US9884910B2 Anti-PDGF-C antibodies Chemistry; Metallurgy 8 Active
US8460655B2 Pharmacological vitreolysis Chemistry; Metallurgy 8 Active
US7875704B2 Anti-PLGF antibody Chemistry; Metallurgy 4 Active
US8834869B2 Pharmacological vitreolysis Chemistry; Metallurgy 1 Active
US9445078B2 Stereo-vision system Human Necessities 1 Active
US9226953B2 Variants of plasminogen and plasmin Chemistry; Metallurgy 1 Active
US8747842B2 Pharmacological vitreolysis Chemistry; Metallurgy 1 Active
US9186394B2 Pharmacological vitreolysis Chemistry; Metallurgy 1 Active
US8920794B2 Method for treating filtration failure after trabeculectomy surgery Human Necessities 0 Active
US8758748B2 Anti-angiogenic therapy Chemistry; Metallurgy 0 Active
US9089552B2 Improving trabeculectomy outcome by administering an anti-placental growth factor antibody Chemistry; Metallurgy 0 Active
US9085617B2 Anti-angiogenic therapy Chemistry; Metallurgy 0 Active
US8993323B2 Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells Chemistry; Metallurgy 0 Active
US9644196B2 Plasminogen and plasmin variants Human Necessities 0 Active
US9770494B2 Pharmacological vitreolysis Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.